Dimensional Fund Advisors Ltd. : Form 8.3 - Kennedy-Wilson

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
115
Dimensional Fund Advisors Ltd. : Form 8.3 - Kennedy-Wilson Holdings Inc - Common stock

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):      The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.    
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree   Kennedy-Wilson Holdings Inc (US4893981070)
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    
(e) Date position held/dealing undertaken:      For an opening position disclosure, state the latest practicable date prior to the disclosure   11 May 2017
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      If it is a cash offer or possible cash offer, state "N/A"   NO If YES, specify which:

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:     USD 0.0001 Common
      Interests   Short positions
  Number   %   Number   %
(1) Relevant securities owned and/or controlled:   2,294,517*   2.01        
(2) Cash-settled derivatives:                  
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:                
                                                                                             TOTAL:   2,294,517   2.01        

*Dimensional Fund Advisors Ltd. and / or its affiliates do not control voting discretion for 229,529 shares.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:    
Details, including nature of the rights concerned and relevant percentages:    

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security   Purchase/sale     Number of securities   Price per unit
Common   Purchase   1,107   USD 20.0500

(b)        Cash-settled derivative transactions

Class of relevant security   Product description e.g. CFD   Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position   Number of reference securities   Price per unit
                 

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

Class of relevant security   Product description e.g. call option   Writing, purchasing, selling, varying etc.   Number of securities to which option relates   Exercise price per unit   Type e.g. American, European etc.   Expiry date   Option money paid/ received per unit
                             

(ii)        Exercise

Class of relevant security   Product description e.g. call option   Exercising/ exercised against   Number of securities   Exercise price per unit
                 

(d)        Other dealings (including subscribing for new securities)

Class of relevant security   Nature of dealing e.g. subscription, conversion   Details   Price per unit (if applicable)
             

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
     

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
     

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached?   NO
Date of disclosure:   12 May 2017
Contact name:   Thomas Hone
Telephone number:   020 3033 3419

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk .  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ELEGOO Slashes Prices up to 54% for 2026 Holiday Deals

Updated Category News Views 30

ELEGOO's 2026 Holiday Strategy: Deep Discounts Welcome to the world of sharp deals and crafty creations as ELEGOO kicks off its Black Friday and Cyber Monday extravaganza. This time, they're slashing prices by up to 54% on their impressive lineup of 3D printers and captivating accessories. Yeah, it's that time of year when wallets might take a hit, but for a good reason....

Continue Reading
Fresenius, WuXi Biologics Blaze New Biosimilars Trail

Updated Category News Views 97

Fresenius Bets Big on Biopharma with WuXi Partnership A deal inked by Fresenius and WuXi Biologics is stirring up the biosimilars pot, aiming to widen Fresenius' grip on the market tenfold. We're not talking small potatoes here; we're talking up to 66 biosimilar molecules against a hefty backdrop of more than €370 billion in originator sales. It's as if they've said,...

Continue Reading
Sirolimus-Coated Balloon Shows Promise in TRANSFORM II

Updated Category News Views 0

Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...

Continue Reading
Tactical Comm Market: $19.39B by 2031 Amid 8.1% CAGR

Updated Category News Views 0

Riding the Tactical Communication Wave Alright, here’s something to chew on over your morning coffee. The tactical communication market is projected to balloon from USD 13.14 billion in 2026 to a whopping USD 19.39 billion by 2031. That’s an 8.1% CAGR if you’re keeping track—no small peanuts. So what's driving this surge? It’s all about security, modernization,...

Continue Reading
SICO Snags $1.6B in New Investor Mandates for 2026

Updated Category News Views 110

SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...

Continue Reading
HashKey and RD Tech Partner for RDUSD Expansion

Updated Category News Views 217

A Partnership with Serious Implications Here's a fresh duo in the financial frontier—HashKey On-Chain and RD Technologies are teaming up in a bid to push the RDUSD stablecoin into the heart of cross-border trade and finance. And why does it matter? Well, in the wild west of digital finance, stablecoins are the solid ground, and these two are planting their flag. It's a...

Continue Reading
2026 Rawlings Gold Glove Award Winners Announced

Updated Category News Views 165

Fielding Excellence on Display: The 2026 Rawlings Gold Glove Awards The Rawlings Gold Glove Awards have once again shone the spotlight on baseball's defensive maestros. Announced by Rawlings Sporting Goods Company, Inc., on November 1, 2026, this year's winners include 11 seasoned veterans and nine greenhorns who claimed their first-ever Gold Gloves. Unveiled during a...

Continue Reading
Skanska's Bold CZK 2.2B Prague Venture: What's Brewing?

Updated Category News Views 40

Skanska Rolls the Dice with CZK 2.2 Billion We got Skanska pushing forward with a beefy CZK 2.2 billion investment, translating to about SEK 1 billion, into a new residential phase right in the heart of Prague. It's part of the grand Emil Kolben District project, tasked with blending modern living with low-energy savvy in a city that's slowly shrugging off its industrial...

Continue Reading
Silicone Fluids Market Forecast Hits $10.15B by 2031

Updated Category News Views 0

Unpacking the Prevailing Expansion The global silicone fluids market is marching on a path to significant growth, projected to hit a hefty $10.15 billion by 2031. Now, if you think that's just another number, let's break down why this matters and how the market is changing its stripes. The Rising Tide of Silicone Applications Silicone fluids are not just sliding under the...

Continue Reading
MetaOptics Expands U.S. Reach with ADR Programme

Updated Category News Views 15

A Bold Move into the U.S. Market MetaOptics Ltd, the semiconductor optics dynamo out of Singapore, is kicking up some investment dust with their American Depositary Receipts (ADR) Programme aimed squarely at expanding its U.S. footprint. And let me tell you, in the game of international market expansion, that's no rookie maneuver. Why ADR? Why Now? So, why is MetaOptics...

Continue Reading

Top 5 Most Recently Viewed Articles

Identity Dental Marketing Tops Rankings for Dentist SEO Strategies

Updated Category News Views 140

Identity Dental Marketing's SEO Excellence for Dentists Identity Dental Marketing has emerged as a leading provider of SEO services specifically tailored for dental practices. The agency is distinguished by its commitment to enhancing online visibility and driving sustainable growth for dentists. Their innovative and customized strategies are designed with the unique...

Continue Reading
Medigene Reveals Breakthroughs in KRAS TCR Technology Advancements

Updated Category News Views 204

Medigene Unveils Major Advances in KRAS TCR Technology Medigene AG, a pioneering oncology platform company, is making important progress in T cell receptor (TCR)-guided therapies that effectively target cancer. At a recent presentation during the ESMO Congress, the company revealed updates about its TCR library focused on the Kirsten rat sarcoma viral oncogene homolog...

Continue Reading
Transforming AI Deployment: AMD and Cohere's Strategic Alliance

Updated Category News Views 245

AMD and Cohere Strengthen Their AI Collaboration AMD recently announced an exciting expansion of its partnership with Cohere, a prominent name in the security-first enterprise AI sector. This collaboration allows Cohere's customers to utilize AMD Instinct™ GPU-powered infrastructure for their comprehensive suite of AI offerings. With this powerful technology,...

Continue Reading
Pacira BioSciences Discusses Board Nominations and Future Plans

Updated Category News Views 176

Pacira BioSciences Advances Governance and Strategy Pacira BioSciences, a leader in innovative non-opioid pain management solutions, has confirmed that DOMA Perpetual Capital Management LLC has nominated three individuals for election to the company’s Board of Directors at its upcoming Annual Meeting for Stockholders. This initiative marks a significant step in the...

Continue Reading
Remittix Set to Unveil Global PayFi App for Easy Payments

Updated Category News Views 207

Remittix Set to Unveil Global PayFi App for Easy Payments As part of its mission to transform international payments and multi-currency finance, Remittix has announced that the official launch date of its groundbreaking PayFi mobile application will be revealed this December. This revolutionary app will facilitate seamless transactions across more than 60 countries and...

Continue Reading